openPR Logo
Press release

maintrac® launches Immunotherapy PDL-1 blood test

07-05-2016 10:14 AM CET | Health & Medicine

Press release from: SIMFO Spezielle Immunologie Forschung + Entwicklung GmbH

Circulating Tumor Cell in the blood (photo by fotolia).

Circulating Tumor Cell in the blood (photo by fotolia).

Immunotherapy was one of the big topics at ASCO (American Society of Clinical Oncology) this year. Because of its potential, ASCO named it "The 2016 Clinical Cancer Advance of the Year". Immunotherapy is among today’s most promising approaches to improving the outcomes of patients.

Obtaining PD-L1 status previously required an invasive tissue biopsy. The highest quality liquid biopsy maintrac ® now makes an invasive procedure obsolete. A simple blood test, the so called maintrac ® liquid biopsy, provides a superior way of testing the PD-L1 status of patients.

The maintrac ® liquid biopsy is a highest quality blood test made in Germany.

More information can be found at www.maintrac-ctc.com

In the Transfusion Medicine Center Bayreuth TZB you can find the SIMFO Research and Development GmbH with focus on precision medicine and the Laboratory Dr. Ulrich Pachmann.
Situated in a small town named Bayreuth in Germany, SIMFO GmbH founded in 1996 by Dr. Ulrich Pachmann and with contributions from family members, SIMFO GmbH has developed an effective weapon to help detect and characterize tumour cells in the blood: the maintrac liquid biopsy.

Transfusion Medicine Center Bayreuth TZB
SIMFO Research and Development & Laboratory Dr. Ulrich Pachmann
Kurpromenade 2
95448 Bayreuth
Germany

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release maintrac® launches Immunotherapy PDL-1 blood test here

News-ID: 347135 • Views:

More Releases from SIMFO Spezielle Immunologie Forschung + Entwicklung GmbH

SIMFO to present maintrac liquid biopsy at the BIO International Convention 2017
SIMFO to present maintrac liquid biopsy at the BIO International Convention 2017
Maintrac Liquid Biopsy recognized by the European Commission as one of the most innovative procedures in circulating tumor cells As one of the 15 most innovative European companies SIMFO GmbH was invited by the European Commission to the Bio International Convention (BIO) 2017 to present maintrac® liquid biopsy under the patronage of the EU. Small and medium-sized enterprises are given the opportunity to obtain comprehensive information about the US healthcare and
Pretreatment testing of SIMFO anticancer drug on patient blood
Pretreatment testing of SIMFO anticancer drug on patient blood
Dubai / Bayreuth - At the 2nd World Conference for Drug Discovery and Therapy, Prof. Dr. Katharina Pachmann (Jena University) presented a worldwide unique approach in oncology that can detect circulating tumor cells in the blood of cancer patients. After tumor removal, any remaining, washed out tumor cells are responsible for the development of metastases, which shorten survival time in most patients. A good, often metastasis-free prognosis of survival is achieved

More Releases for Circulating

Circulating Tumour DNA Market Size Report 2034
On April 25, 2025, Exactitude Consultancy., Ltd. released a research report titled "Circulating Tumour DNA Market". This report covers the global Circulating Tumor DNA market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends.
Key Trend Reshaping the Circulating Fluid Bed Boilers Market in 2025: Strategic …
What combination of drivers is leading to accelerated growth in the circulating fluid bed boilers market? The circulating fluid bed boiler market is predicted to expand due to a surge in coal consumption. Coal, a black rock extracted from the earth, is used as fuel. These boilers are typically found in coal-fired power plants, where they create steam to run large turbines, and the mineral components of coal are converted into
Circulating Water Baths Market Size 2024 to 2031.
Market Overview and Report Coverage A circulating water bath is a laboratory device used to heat or cool samples in a controlled environment. These baths are essential equipment in various industries such as healthcare, pharmaceuticals, and research labs for conducting experiments that require precise temperature control. The circulating water baths market is expected to witness significant growth in the coming years, with a projected CAGR of 5.00% during the forecasted
Circulating Tumor Cells Market 2023 | Detailed Report
The Circulating Tumor Cells report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research. The Circulating Tumor Cells research report recognizes and
Global Circulating Cell-Free DNA Diagnostics Market
According to a new market research report published by Global Market Estimates, the Global Circulating Cell-Free DNA (ccfDNA) Diagnostics Market is projected to grow from USD 4.9 billion in 2022 to USD 13.1 billion in 2027 at a CAGR of 21.7% from 2022 to 2027. Hoffmann-La Roche, Natera Inc., Illumina Inc., Agena Bioscience, Paragon Genomics, Thermo Fisher Scientific, Bio-Rad Laboratories, Lucence Health, and Eurofins among others are some key players in
Global Circulating Thermostats Market Analysis by 2020-2025
Scope of the Report: The global Circulating Thermostats market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. Market segmentation Circulating Thermostats market is split by Type and by Application. For the period 2015-2025, the growth among segments